Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

Author:

Németh Bertalan1ORCID,Kamusheva Maria2ORCID,Mitkova Zornitsa2ORCID,Petykó Zsuzsanna Ida1ORCID,Zemplényi Antal13ORCID,Dimitrova Maria2ORCID,Tachkov Konstantin2ORCID,Balkányi László4ORCID,Czech Marcin5ORCID,Dawoud Dalia67ORCID,Goettsch Wim89ORCID,Hren Rok10,Knies Saskia9ORCID,Lorenzovici László1112ORCID,Maravic Zorana13ORCID,Piniazhko Oresta14ORCID,Zerovnik Spela15,Kaló Zoltán116ORCID

Affiliation:

1. Syreon Research Institute, Budapest, HU 1142, Hungary

2. Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria

3. Center for Health Technology Assessment & Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary

4. Medical Informatics R&D Center, Pannon University, Veszprém, HU 8200, Hungary

5. Department of Pharmacoeconomics, Institute of Mother & Child, Warsaw, PL 01-211, Poland

6. Science Policy & Research Programme, Science Evidence & Analytics Directorate, National Institute for Health & Care Excellence (NICE), London, United Kingdom

7. Cairo University, Faculty of Pharmacy, Cairo, Egypt

8. Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands

9. National Health Care Institute, Diemen, NL 1120 AH, The Netherlands

10. Faculty of Mathematics & Physics, University of Ljubljana, Ljubljana, Slovenia

11. Syreon Research Romania, Tirgu Mures, RO 540004, Romania

12. G. E. Palade University of Medicine, Pharmacy, Science & Technology, Tirgu Mures, RO 540142, Romania

13. Digestive Cancers Europe, Brussels, BE 1040, Belgium

14. HTA Department of State Expert Centre of the Ministry of Health of Ukraine, Kyiv, Ukraine

15. Ministry of Health, Ljubljana, Slovenia

16. Centre for Health Technology Assessment, Semmelweis University, Budapest, HU 1091 Hungary

Abstract

Aim:Real-world data and real-world evidence (RWE) are becoming more important for healthcare decision making and health technology assessment. We aimed to propose solutions to overcome barriers preventing Central and Eastern European (CEE) countries from using RWE generated in Western Europe.Materials & methods:To achieve this, following a scoping review and a webinar, the most important barriers were selected through a survey. A workshop was held with CEE experts to discuss proposed solutions.Results:Based on survey results, we selected the nine most important barriers. Multiple solutions were proposed, for example, the need for a European consensus, and building trust in using RWE.Conclusion:Through collaboration with regional stakeholders, we proposed a list of solutions to overcome barriers on transferring RWE from Western Europe to CEE countries.

Funder

Horizon 2020 Framework Programme

Publisher

Becaris Publishing Limited

Subject

Health Policy

Reference30 articles.

1. The new definition of health technology assessment: a milestone in international collaboration;O'Rourke B;Int. J. Technol. Assess. Health Care,2020

2. The transferability of health technology assessment: the European perspective with focus on Central and Eastern European countries;Németh B;Expert Rev. Pharmacoecon. Outcomes Res.,2020

3. What is real-world data? A review of definitions based on literature and stakeholder interviews;Makady A;Value Health,2017

4. Haute Autorité de santé (HAS). Real-world studies for the assessment of medicinal products and medical devices. www.has-sante.fr/upload/docs/application/pdf/2021-06/real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf

5. US Department of Health and Human Services Food and Drug Administration (FDA). Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions. www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3